OncoMatch/Clinical Trials/NCT05766891

Opioid-Sparing Effects of Nurse-Delivered Hypnosis During Breast Cancer Surgery

Is NCT05766891 recruiting? Yes, currently enrolling (May 2026). This Phase 2/3 trial studies non-drug interventions for breast cancer.

Phase 2/3RecruitingM.D. Anderson Cancer CenterNCT05766891Data as of May 2026

To hypnosedation alone given before and during surgery on reducing opioid use after surgery compared to standard general anesthesia given alone or with hypnosedation.

Check if I qualify

Extracted eligibility criteria

Cancer type

Breast Carcinoma

Prior therapy

Cannot have received: chemotherapy

Structured fields extracted by AI. May contain errors — verify against the official protocol.

US trial sites

M D Anderson Cancer Center · Houston, Texas

Showing up to 5 US sites. See all sites on ClinicalTrials.gov →

Could you qualify for this trial?

Enter your biomarker results to see how this trial's eligibility criteria match your specific cancer profile.

Check if I qualify